Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
Pfeffer, P., Ali, N., Murray, R., Ulrik, C., Tran, T., Maspero, J., Peters, M., Christoff, G., Sadatsafavi, M., Torres-Duque, C. A., Altraja, A., Lehtimäki, L., Papadopoulos, N., Salvi, S., Costello, R. W., Cushen, B., Heffler, E., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., Kuna, P., Fonseca, J., Al-Lehebi, R., Rhee, C. K., Llano, L. P. d., Perng, D., Mahboub, B., Wang, E., Goh, Y. Y. C., Lyu, J., Newell, A., Alacqua, M., Bhutani, M., Bjermer, L., Björnsdóttir, U. S., Bourdin, A., Bülow, A. V., Busby, J., Canonica, W., Cosio, B. G., Dorscheid, D., Esquerre, M. M., FitzGerald, M., Gil, E. G., Gibson, P. G., Heaney, L., Hew, M., Hilberg, O., Hoyte, F., Jackson, D., Koh, M., Ko, H., Lee, J. H., Lehmann, S., Loureiro, C. C., Ludviksdottir, D., Menzies-Gow, A., Mitchell, P., Papaioannou, A., Popov, T., Porsbjerg, C., Salameh, L., Sirena, C., Taillé, C., Taube, C., Tohda, Y., Wechsler, M. E., Price, D.
Characteristics associated with clinical remission in patients with severe asthma who initiate biologics
Llano, L. P. d., Scelo, G., Tran, T. N., Le, T. T., Martin, N., Fagerås, M., Menzies-Gow, A. N., Wang, E., Wechsler, M. E., Walter Canonica, G., Heffler, E., Peters, M., Gibson, P. G., Al-Ahmad, M., Bergeron, C., Sadatsafavi, M., Cosio, B. G., Kuna, P., Perng, D. W., Iwanaga, T., Torres-Duque, C. A., Larenas-Linnemann, D., Mahboub, B., Papadopoulos, N. G., Al-Lehebi, R., Fonseca, J. A., Rhee, C. K., Maspero, J., Koh, M. S., Christoff, G. C., Popov, T. A., Kwiatek, J., Carter, V., Goh, C., Bulathsinhala, L., Beastall, A., Price, D.
ERS 2023 International Congress
Contributions to Conferences: Abstracts
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST Quality Standards: an observational longitudinal study
Halpin, D. M., Dickens, A. P., Skinner, D., Murray, R. B., Singh, M., Hickman, K., Carter, V., Couper, A., Evans, A., Pullen, R., Menon, S., Morris, T., Muellerova, H., Bafadhel, M., Chalmers, J., Devereux, G., Gibson, M., Hurst, J. R., Jones, R., Kostikas, K., Quint, J., Singh, D., van Melle, M., Wilkinson, T. M., Price, D.
The Lancet Regional Health - Europe, vol. 29, 100619
Questions in Mild Asthma: An Official American Thoracic Society Research Statement
Mohan, A., Lugogo, N. L., Hanania, N. A., Reddel, H. K., Akuthota, P., O'Byrne, P. M., Guilbert, T., Papi, A., Price, D., Jenkins, C. R., Kraft, M., Bacharier, L. B., Boulet, L., Yawn, B. P., Pleasants, R., Lazarus, S. C., Beasley, R., Gauvreau, G., Israel, E., Schneider-Futschik, E. K., Yorgancioglu, A., Martinez, F., Moore, W., Sumino, K.
American journal of respiratory and critical care medicine, vol. 207, no. 11, pp. e77-e96
Association Between T2-related Comorbidities and Effectiveness of Biologics in Adult Patients From the International Severe Asthma Registry
Price, D., Scelo, G., Porsbjerg, C., Murray, R., Tran, T. N., Martin, N., Al-Ahmad, M., Al-Lehebi, R. O., Bergeron, C., Busby, J., Canonica, G., Christoff, G., Rhee, C., Cosio, B. G., Fonseca, J., Heaney, L., Heffler, E., Popov, T., Sadatsafavi, M., Salvi, S., Torres-Duque, C. A., Wang, E., Wechsler, M. E., Hew, M., Iwanaga, T., Jackson, D. J., Kuna, P., Larenas-Linnemann, D., Mahboub, B., Máspero, J., Menzies-Gow, A., Papadopoulos, N., Perng, D., Peters, M., Pfeffer, P., PRISM working group
The influence of mixing inhaler devices on inhaler technique in COPD
Kerkhof, M., Driessen, M., Gerritsma, Y., Bosnic-Anticevich, S., Correia de Sousa, J., Dekhuijzen, R., Kerstjens, H. A., Leving, M., Price, D., Tsiligianni, I., Usmani, O.
Biologic Responders and Super-responders in the International Severe Asthma Registry
Denton, E., Hew, M., Murray, R., Bulathsinhala, L., Trung, T. N., Martin, N., Al-Ahmad, M., Altraja, A., Celis-Preciado, C. A., Al-Lehebi, R. O., Bergeron, C., Bosnic-Anticevich, S. Z., Bourdin, A., Brusselle, G., Canonica, G. W., Charriot, J., Christoff, G. C., L., C., Cosio, B. G., Costello, R. W., Cushen, B., Fonseca, J., Gibson, P. G., Heaney, L. G., Iwanaga, T., Koh, M., Lehtimäki, L., Máspero, J., Mahboub, B., Mitchell, P., Papadopoulos, N., Perez-De-Llano, L., Perng, D., Peters, M., Pfeffer, P. E., Popov, T., Porsbjerg, C., Rhee, C., Roche, N., Sadatsafavi, M., Salvi, S. S., Sheu, C., Torres-Duque, C. A., Ulrik, C. S., Upham, J. W., Wang, E., Wechsler, M. E., Price, D.
Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap
Kocks, J. W., Cao, H., Holzhauer, B., Kaplan, A., FitzGerald, J. M., Kostikas, K., Price, D., Reddel, H. K., Tsiligianni, I., Vogelmeier, C. F., Bostel, S., Mastoridis, P.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 5, pp. 1463-1474
Chronic Airways Assessment Test: Psychometric properties in patients with asthma and/or COPD
Tomaszewski, E. L., Atkinson, M. J., Janson, C., Karlsson, N., Make, B., Price, D., Reddel, H. K., NOVELTY study investigators, NOVELTY Scientific Community
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in primary care: study protocol for a cluster randomised controlled implementation trial
McClatchey, K., Hammersley, V., Steed, L., Sheringham, J., Marsh, V., Barat, A., Delaney, B., Hamborg, T., Fitzsimmons, D. F., Holmes, S., Jackson, T., Ehrlic, E., Morgan, N., Saxon, A., Preston, M., Price, D., Taylor, S. J., Pinnock, H., IMP2ART Programme Group.
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
Haughney, J., Tran, T. N., Heatley, H., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Chan, J. S. K., Price, D.
npj Primary Care Respiratory Medicine, vol. 33, no. 1, 9
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S. Z., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D., Beekman, M., Stewart, D.
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
Lyu, J., Rhee, C. K., Tran, T. N., Katial, R., Martin, N., Peters, M., Denton, E., Upham, J. W., Bardin, P. G., Cochrane,, B., Middleton, P. G., Reynolds, P. M., Perng, D. W., Wang, H., Sheu, C., Tsai, M., Wan-Chun Huang, E., Chien, Y., Hsu, J., Fu, P., Lin, C., Lin, S., Shen, S., Liu, S., Lee, K., Chiu, K., Lin, H., Lin, M., Chou, C., Salvi, S., Cho, Y. S., Yoo, K. H., Iwanaga, T., Tohda, Y., Fujimoto, H., Tanaka, H., Nogami, K., Sekiya, K., Matsunaga, M., Soichiro, H., Fujisawa, T., Nagano, T., Kobayashi, T., Oguma, T., Nishimura, Y., Murray, R. B., Bulathsinhala, L., Joshi, I., Eleangovan, N., Skinner, D., Carter, V., Price, C., Price, D.
Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
Park, H. Y., Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D.
The association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
Price, D., Jenkins, C., Hancock, K., Hancock, K., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Bateman, E. D.
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
Pavord, I. D., Tran, T. N., Jones, R., Nuevo, J., van den Berge, M., Brusselle, G., Menzies-Gow, A., Skinner, D., Carter, V., Kocks, J. W. H., Price, D.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543
Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
Heatley, H., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
Leving, M., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Román-Rodríguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Usmani, O., Kocks, J.
npj Primary Care Respiratory Medicine, vol. 32, 59
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
Systemic Corticosteroids in Asthma: A Call to Action From World Allergy Organization and Respiratory Effectiveness Group
Bleecker, E. R., Al-Ahmad, M., Bjermer, L., Caminati, M., Walter Canonica, G., Kaplan, A., Papadopoulos, N. G., Roche, N., Ryan, D., Tohda, Y., Price, D.
World Allergy Organization Journal, vol. 15, no. 12, 100726
Adrenal function recovery after durable OCS-sparing with benralizumab in the PONENTE study
Menzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., Kreindler, J., Burden, A., de Giorgio-Miller, A., Faison, S., Padilla, K., Martin, U. J., Garcia Gil, E., PONENTE Study Group
European Respiratory Journal, vol. 60, no. 6, 2103226
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
Price, D., Burkill, S., Eileen, W., Wechsler, M. E., Denton, E., Tran, T. N., Martin, N., Katial, R., Barker, P., Maspero, J. F., Hew, M., Brusselle, G., Christoff, G., Sadatsafavi, M., Torres-Duque, C. A., Porsbjerg, C. M., Ulrik, C., Hansen, S., Altraja, A., Bourdin, A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Cosio, B. G., Siyue, M. K., Kirenga, B., Sheu, C., Tsai, M., Mahboub, B., Busby, J., Heaney, L. G., Pfeffer, P. E., Patel, P. H., Hoyte, F. L., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Henley, W., ISAR EMBER
European Respiratory Society (ERS) International Congress., 2814
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
Loewenthal, L., Busby, J., McDowell, R. D., Brown, T., Burhan, H., Chaudhuri, R., Dennison, P., Dodd, J. W., Doe, S., Faruqi, S., Gore, R., Idris, E., Jackson, D. J., Patel, M., Pantin, T., Pavord, I. D., Pfeffer, P. E., Price, D., Siddiqui, S., Heaney, L. G., Menzies-Gow, A.
European Respiratory Society (ERS) International Congress., 308
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
European Respiratory Society (ERS) International Congress., pp. 1552
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Price, D.
European Respiratory Society (ERS) International Congress., 3402
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S., Porsbjerg, C. M., Bourdin, A., Tran, T. N., Martin, N., Katial, R., Barker, P., Wechsler, M. E., Maspero, J. F., Bosnic-Anticevich, S., Chung, L. P., Katsoulotos, G., Christoff, G., Popov, T. A., Sadatsafavi, M., Torres-Duque, C. A., Ulrik, C., Assing, K. D., Hansen, S., Altraja, A., Lehtimäki, L. A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Amaral, R., Al-Lehebi, R., Perez de Llano, L., Kirenga, B., Tsai, M., Mahboub, B., Pfeffer, P. E., Henley, W., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Price, D., ISAR IGNITE
European Respiratory Society (ERS) International Congress., 3305
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Papi, A., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
European Respiratory Society (ERS) International Congress., 2125
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
Chen, W., Tran, T. N., Sadatsafavi, M., Garcia Gil, E., Alacqua, M., Menzies-Gow, A., Heaney, L. G., Pfeffer, P. E., Maspero, J. F., Peters, M., Christoff, G., Bhutani, M., Torres-Duque, C. A., Ulrik, C., Altraja, A., Lehtimäki, L., Taillé, C., Papaioannou, A. I., Salvi, S., Costello, R. W., Canonica, G. W., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., Kuna, P., Fonseca, J. A., Al-Lehebi, R., Siyue, M. K., Rhee, C. K., Perez de Llano, L., Jones, R. C., Perng, D. W., Eileen, W., Hoyte, F. L., Wong, N. C. B., Lyu, J., Ariti, C., Murray, R., Goh, C., Joshi, I., Eleangovan, N., Price, D., ISAR GLITTER Working Group
European Respiratory Society (ERS) International Congress., 3405
P186 Facilitators to recruiting COPD patients to an adherence intervention trial
Dickens, A., Halpin, D., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
British Thoracic Society Winter Meeting 2022, pp. A72-A73
Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy
Chen, W., Sadatsafavi, M., Tran, T. N., Murray, R. B., Wong, N. C. B., Ali, N., Ariti, C., Gil, E. G., Newell, A. P., Alacqua, M., Al-Ahmad, M., Altraja, H., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A. S., Bourdin, A., Bulathsinhala, L., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Yoo, K. H., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Siyue, M. K., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L. A., Lyu, J., Mahboub, B., Maspero, J. F., Menzies-Gow, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez de Llano, L., Perng, D. W., Peters, M., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Suppli Ulrik, C., Ra, S. W., Eileen, W., Wechsler, M. E., Price, D.
Journal of Asthma and Allergy, vol. 15, no. 15, pp. 1491—1510
